Darbelife 40mcg Injection

Price 2300.0 INR/

Get a Price/Quote

MOQ : 6 Pieces

Darbelife 40mcg Injection Specification

Pacakaging (Quantity Per Box)
1

Indication
Treatment of Anemia in Chronic Kidney Disease

Salt Composition
Darbepoetin alfa

Dosage Form
Injection

Origin of Medicine
India

Drug Type
Injection

Ingredients
Darbelife 40 mcg Injection (PFS) contains darbepoetin alfa, an erythropoiesis-stimulating agent used to treat anemia caused by chronic kidney disease (CKD) in adults and children. It works by stimulating red blood cell production, helping improve hemoglobin levels and reduce anemia-related symptoms such as fatigue and weakness. Blood tests and blood pressure are regularly monitored to ensure safe and effective treatment. Darbelife is not recommended for patients with uncontrolled hypertension and should be used with caution in those with liver disease, seizures, sickle cell anemia, or a history of poor response to anemia therapy. Use during pregnancy should be carefully considered, breastfeeding is not advised, and treatment in infants or children should be done only under strict medical supervision.

Function
Other

Recommended For
Treatment of Anemia in Chronic Kidney Disease

Suitable For
Suitable For All

Quantity
1 Pieces

Storage Instructions
Store in a refrigerator (2 - 8 C)

Darbelife 40mcg Injection Trade Information

Minimum Order Quantity
6 Pieces

Delivery Time
2 Days

About Darbelife 40mcg Injection

Darbelife 40 mcg Injection (PFS) contains darbepoetin alfa, an erythropoiesis-stimulating agent used to treat anemia caused by chronic kidney disease (CKD) in adults and children. It works by stimulating red blood cell production, helping improve hemoglobin levels and reduce anemia-related symptoms such as fatigue and weakness. Blood tests and blood pressure are regularly monitored to ensure safe and effective treatment.

Darbelife is not recommended for patients with uncontrolled hypertension and should be used with caution in those with liver disease, seizures, sickle cell anemia, or a history of poor response to anemia therapy. Use during pregnancy should be carefully considered, breastfeeding is not advised, and treatment in infants or children should be done only under strict medical supervision.

Tell us about your requirement